377 related articles for article (PubMed ID: 26061564)
1. Rp-cAMPS Prodrugs Reveal the cAMP Dependence of First-Phase Glucose-Stimulated Insulin Secretion.
Schwede F; Chepurny OG; Kaufholz M; Bertinetti D; Leech CA; Cabrera O; Zhu Y; Mei F; Cheng X; Manning Fox JE; MacDonald PE; Genieser HG; Herberg FW; Holz GG
Mol Endocrinol; 2015 Jul; 29(7):988-1005. PubMed ID: 26061564
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Glucose-Stimulated Cdc42-Pak1 Activation and Insulin Secretion by a Selective Epac Activator in Type 2 Diabetic Human Islets.
Veluthakal R; Chepurny OG; Leech CA; Schwede F; Holz GG; Thurmond DC
Diabetes; 2018 Oct; 67(10):1999-2011. PubMed ID: 29986926
[TBL] [Abstract][Full Text] [Related]
3. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.
Kang G; Chepurny OG; Malester B; Rindler MJ; Rehmann H; Bos JL; Schwede F; Coetzee WA; Holz GG
J Physiol; 2006 Jun; 573(Pt 3):595-609. PubMed ID: 16613879
[TBL] [Abstract][Full Text] [Related]
4. PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans.
Chepurny OG; Kelley GG; Dzhura I; Leech CA; Roe MW; Dzhura E; Li X; Schwede F; Genieser HG; Holz GG
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E622-33. PubMed ID: 20009023
[TBL] [Abstract][Full Text] [Related]
5. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of cAMP-dependent protein kinase induces behavioural and neurological antidepressant-like effects in rats.
Liebenberg N; Müller HK; Fischer CW; Harvey BH; Brink CB; Elfving B; Wegener G
Neurosci Lett; 2011 Jul; 498(2):158-61. PubMed ID: 21596096
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase C-ε links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans.
Dzhura I; Chepurny OG; Leech CA; Roe MW; Dzhura E; Xu X; Lu Y; Schwede F; Genieser HG; Smrcka AV; Holz GG
Islets; 2011; 3(3):121-8. PubMed ID: 21478675
[TBL] [Abstract][Full Text] [Related]
8. Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A.
Persaud SJ; Jones PM; Howell SL
Biochem Biophys Res Commun; 1990 Dec; 173(3):833-9. PubMed ID: 2176491
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2'-O-Me-cAMP-AM.
Chepurny OG; Leech CA; Kelley GG; Dzhura I; Dzhura E; Li X; Rindler MJ; Schwede F; Genieser HG; Holz GG
J Biol Chem; 2009 Apr; 284(16):10728-36. PubMed ID: 19244230
[TBL] [Abstract][Full Text] [Related]
10. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway.
Maes M; Kenis G; Kubera M; De Baets M; Steinbusch H; Bosmans E
Int Immunopharmacol; 2005 Mar; 5(3):609-18. PubMed ID: 15683856
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
12. Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase.
Seldon PM; Meja KK; Giembycz MA
Pulm Pharmacol Ther; 2005; 18(4):277-84. PubMed ID: 15777610
[TBL] [Abstract][Full Text] [Related]
13. Heterologous desensitization of insulin secretion by GIP (glucose-dependent insulinotropic peptide) in INS-1 cells: the significance of Galphai2 and investigations on the mechanism involved.
Rucha A; Verspohl EJ
Cell Biochem Funct; 2005; 23(3):205-12. PubMed ID: 15376236
[TBL] [Abstract][Full Text] [Related]
14. Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries.
Jackson WF
Pharmacology; 1996 Apr; 52(4):226-34. PubMed ID: 8841085
[TBL] [Abstract][Full Text] [Related]
15. cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery.
Kawada T; Toyosato A; Islam MO; Yoshida Y; Imai S
Eur J Pharmacol; 1997 Mar; 323(1):75-82. PubMed ID: 9105879
[TBL] [Abstract][Full Text] [Related]
16. Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts.
Haag S; Warnken M; Juergens UR; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):617-30. PubMed ID: 18648773
[TBL] [Abstract][Full Text] [Related]
17. cAMP protects neutrophils against TNF-alpha-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac).
Krakstad C; Christensen AE; Døskeland SO
J Leukoc Biol; 2004 Sep; 76(3):641-7. PubMed ID: 15178699
[TBL] [Abstract][Full Text] [Related]
18. cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing beta-cells.
McQuaid TS; Saleh MC; Joseph JW; Gyulkhandanyan A; Manning-Fox JE; MacLellan JD; Wheeler MB; Chan CB
J Endocrinol; 2006 Sep; 190(3):669-80. PubMed ID: 17003268
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cAMP protein kinase A signaling determines improved insulin secretion in a clonal insulin-producing beta-cell line (INS-1 832/13).
Yang S; Fransson U; Fagerhus L; Holst LS; Hohmeier HE; Renström E; Mulder H
Mol Endocrinol; 2004 Sep; 18(9):2312-20. PubMed ID: 15166255
[TBL] [Abstract][Full Text] [Related]
20. A Membrane Permeable Prodrug of S223 for Selective Epac2 Activation in Living Cells.
Xu Y; Schwede F; Wienk H; Tengholm A; Rehmann H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
